Cargando…

Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants

Detalles Bibliográficos
Autores principales: Au, Wing Ying, Ye, Chengjin, Briner, Sydney Leigh, Suarez, Gianmarco Domenico, Han, Jeewon, Xu, Xinzhou, Park, Jun-Gyu, Brindley, Melinda Ann, Martinez-Sobrido, Luis, Cheung, Peter Pak-Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889726/
https://www.ncbi.nlm.nih.gov/pubmed/35245585
http://dx.doi.org/10.1016/j.jinf.2022.02.030
_version_ 1784661467770912768
author Au, Wing Ying
Ye, Chengjin
Briner, Sydney Leigh
Suarez, Gianmarco Domenico
Han, Jeewon
Xu, Xinzhou
Park, Jun-Gyu
Brindley, Melinda Ann
Martinez-Sobrido, Luis
Cheung, Peter Pak-Hang
author_facet Au, Wing Ying
Ye, Chengjin
Briner, Sydney Leigh
Suarez, Gianmarco Domenico
Han, Jeewon
Xu, Xinzhou
Park, Jun-Gyu
Brindley, Melinda Ann
Martinez-Sobrido, Luis
Cheung, Peter Pak-Hang
author_sort Au, Wing Ying
collection PubMed
description
format Online
Article
Text
id pubmed-8889726
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-88897262022-03-02 Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants Au, Wing Ying Ye, Chengjin Briner, Sydney Leigh Suarez, Gianmarco Domenico Han, Jeewon Xu, Xinzhou Park, Jun-Gyu Brindley, Melinda Ann Martinez-Sobrido, Luis Cheung, Peter Pak-Hang J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-05 2022-03-02 /pmc/articles/PMC8889726/ /pubmed/35245585 http://dx.doi.org/10.1016/j.jinf.2022.02.030 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Au, Wing Ying
Ye, Chengjin
Briner, Sydney Leigh
Suarez, Gianmarco Domenico
Han, Jeewon
Xu, Xinzhou
Park, Jun-Gyu
Brindley, Melinda Ann
Martinez-Sobrido, Luis
Cheung, Peter Pak-Hang
Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants
title Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants
title_full Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants
title_fullStr Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants
title_full_unstemmed Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants
title_short Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants
title_sort systematic comparison between bnt162b2 and coronavac in the seroprotection against sars-cov-2 alpha, beta, gamma, and delta variants
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889726/
https://www.ncbi.nlm.nih.gov/pubmed/35245585
http://dx.doi.org/10.1016/j.jinf.2022.02.030
work_keys_str_mv AT auwingying systematiccomparisonbetweenbnt162b2andcoronavacintheseroprotectionagainstsarscov2alphabetagammaanddeltavariants
AT yechengjin systematiccomparisonbetweenbnt162b2andcoronavacintheseroprotectionagainstsarscov2alphabetagammaanddeltavariants
AT brinersydneyleigh systematiccomparisonbetweenbnt162b2andcoronavacintheseroprotectionagainstsarscov2alphabetagammaanddeltavariants
AT suarezgianmarcodomenico systematiccomparisonbetweenbnt162b2andcoronavacintheseroprotectionagainstsarscov2alphabetagammaanddeltavariants
AT hanjeewon systematiccomparisonbetweenbnt162b2andcoronavacintheseroprotectionagainstsarscov2alphabetagammaanddeltavariants
AT xuxinzhou systematiccomparisonbetweenbnt162b2andcoronavacintheseroprotectionagainstsarscov2alphabetagammaanddeltavariants
AT parkjungyu systematiccomparisonbetweenbnt162b2andcoronavacintheseroprotectionagainstsarscov2alphabetagammaanddeltavariants
AT brindleymelindaann systematiccomparisonbetweenbnt162b2andcoronavacintheseroprotectionagainstsarscov2alphabetagammaanddeltavariants
AT martinezsobridoluis systematiccomparisonbetweenbnt162b2andcoronavacintheseroprotectionagainstsarscov2alphabetagammaanddeltavariants
AT cheungpeterpakhang systematiccomparisonbetweenbnt162b2andcoronavacintheseroprotectionagainstsarscov2alphabetagammaanddeltavariants